CNBC September 20, 2023
Stefan Sykes

Key Points

– Tobacco giant Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

– The company has been making inroads into the wellness and health-care space in recent years as it pivots toward becoming a business focused on smoke-free products and respiratory medicines.

– More recently, the division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options to try to grow its wellness and health-care division.

Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

The tobacco company, which makes Marlboro cigarettes, made inroads into the health care and wellness space in 2021 with the acquisition of Vectura, a U.K.-based pharmaceutical company...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Trends, Wellness
“Deregulation” on the Menu: Big Changes for Wellness and CDS Technologies
FDA Issues Key Guidance Updates for Digital Health and Wellness
Apple Fitness+ Unveils Ground-Breaking ‘Make Your Fitness Comeback’
Healthy New Year: The 7 Latest Fitness And Wellness Tech For 2026
5 wellness 'trends' actually backed by research: Cardiology edition

Share Article